This is an investigational study. Pembrolizumab is FDA approved and commercially approved for many types of cancer, including classical Hodgkin Lymphoma. EBRT will be performed using FDA approved and commercially available methods. The combination of EBRT with Pembrolizumab to treat NHL is investigational.